AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
49 hedge funds and large institutions have $30.5M invested in Agile Therapeutics in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
47% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 19
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 16
Holders
49
Holding in Top 10
1
Calls
$363K
Puts
$48K
Top Buyers
| 1 | +$220K | |
| 2 | +$206K | |
| 3 | +$156K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$67.4K |
| 5 |
SGI
Summit Global Investments
Bountiful,
Utah
|
+$15.4K |
Top Sellers
| 1 | -$778K | |
| 2 | -$542K | |
| 3 | -$321K | |
| 4 |
Goldman Sachs
New York
|
-$305K |
| 5 |
Morgan Stanley
New York
|
-$240K |